ANIPRYL DIN 02229983
Health Canada record
| Active ingredient(s) | SELEGILINE HYDROCHLORIDE 30 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 18-Apr-1997 |
| Current status date | 20-Jul-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SELEGILINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02230641 | SELEGILINE | AA PHARMA INC | Tablet | SELEGILINE HYDROCHLORIDE 5 MG | Marketed |
| 02184508 | ANIPRYL | ZOETIS CANADA INC | Tablet | SELEGILINE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 02184516 | ANIPRYL | ZOETIS CANADA INC | Tablet | SELEGILINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02184524 | ANIPRYL | ZOETIS CANADA INC | Tablet | SELEGILINE HYDROCHLORIDE 15 MG | Cancelled Post Market |
| 02229982 | ANIPRYL | ZOETIS CANADA INC | Tablet | SELEGILINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02238340 | DOM-SELEGILINE | DOMINION PHARMACAL | Tablet | SELEGILINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02123312 | ELDEPRYL - 5MG TAB | DRAXIS HEALTH INC. | Tablet | SELEGILINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02237289 | MED SELEGILINE | MEDICAN PHARMA INCORPORATED | Tablet | SELEGILINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02231036 | MYLAN-SELEGILINE | MYLAN PHARMACEUTICALS ULC | Tablet | SELEGILINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02230717 | NU-SELEGILINE | NU-PHARM INC | Tablet | SELEGILINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02238102 | PMS-SELEGILINE | PHARMASCIENCE INC | Tablet | SELEGILINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02238319 | SELEGILINE | PHARMEL INC | Tablet | SELEGILINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02231479 | SELEGILINE-5 | PRO DOC LIMITEE | Tablet | SELEGILINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02068087 | TEVA-SELEGILINE | TEVA CANADA LIMITED | Tablet | SELEGILINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 15259 | 2014-02-13 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 6565 | 1998-06-26 | New Drug Submission (NDS) | |
| 6407 | 1996-11-13 | New Drug Submission (NDS) |
International API supply for SELEGILINE HYDROCHLORIDE
4 valid EDQM Certificates of Suitability from 4 holders. 2 active FDA Drug Master Files.
Request a quote for ANIPRYL